Please assess the completion status of the following clinical trial:

Trial Title: Adherence to Medical Treatments for Telemedicine Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Phase 1 (Controls)~  * 18 - 75 years old~ * Good general health (self-reported), with no history of cerebral vascular accident (CVA)~ * English-speaking~ * Willingness and ability to comply with scheduled visits and study procedures~Phase 2 (Stroke Patients)~* 18 - 75 years old~* English-speaking~* Willingness and ability to comply with scheduled visits and study procedures~* Have requirements for home- based therapy regimens (i.e. physical/occupational therapy)~* Require medications for secondary stroke prevention (e.g. antithrombotic therapy to prevent ischemic stroke, stroke risk factor management with blood pressure, diabetes, cholesterol medications).~* Have a Modified Rankin Scale for Neurologic Disability (MDS) of 2 - 4~Exclusion Criteria:~* Phase 1 (Controls)~  * Pregnant women, fetuses, neonates, children, prisoners, cognitively impaired, non-English speaking subjects~ * Prohibitive cognitive impairments or language deficits~ * Does not have wireless internet connection at home~Phase 2 (Stroke Patients)~* Pregnant women, fetuses, neonates, children, prisoners, cognitively impaired, non-English speaking subjects~* Have a Modified Rankin Scale for Neurologic Disability (MDS) of 0-1 or 5~* Prohibitive cognitive impairments or language deficits~* Significant weakness, dystonia, or spasticity that will prevent proper use and response to the Apple Watch device~* Live in nursing home or rehabilitation facility~* Does not have wireless internet connection at home

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- MedRem application (Type: EXPERIMENTAL): MedRem smartwatch application

Based on this trial design, predict the completion outcome and termination type (if applicable).